567 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
Rank Status Study
1 Recruiting Mediterranean Diet Versus Hypocaloric Diet in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet, restricted calorie;   Other: hypocaloric diet, restricted calorie
2 Recruiting Mediterranean Diet as Treatment for Normal Weight Women With PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet;   Other: normocaloric diet
3 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
4 Not yet recruiting TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Biological: TPIV200;   Biological: Durvalumab
5 Recruiting Study to Evaluate CORT125134 in Combination With Nab-paclitaxel in Patients With Solid Tumors
Conditions: Solid Tumors;   Cellular Diagnosis, Ovarian Epithelial Cancer;   Breast Cancer
Intervention: Drug: CORT125134 with nab-paclitaxel
6 Recruiting The Women Choosing Surgical Prevention (WISP) Trial
Condition: Hereditary Breast and Ovarian Cancer Syndrome
Interventions: Procedure: Salpingectomy;   Procedure: Oophorectomy;   Behavioral: Questionnaires
7 Not yet recruiting GL-ONC1 Oncolytic Immunotherapy in Patients With Platinum-resistant Ovarian Cancer
Conditions: Ovarian Cancer;   Peritoneal Carcinomatosis;   Fallopian Tube Cancer
Intervention: Biological: GL-ONC1
8 Not yet recruiting Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer
Condition: Ovarian Cancer
Intervention:
9 Not yet recruiting Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
Conditions: Primary Ovarian Insufficiency;   Menopause, Premature
Intervention: Drug: Drospirenone and ethinyl estradiol combination (Yasmin)
10 Not yet recruiting Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: Anetumab ravtansine (BAY94-9343);   Drug: Pegylated Liposomal Doxorubicin
11 Not yet recruiting OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Oral contraceptive pill combination of ethyl estradiol and Cyproterone acetate;   Drug: Metformin 1500mgs per day
12 Recruiting Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer
Conditions: Ascites;   Ovarian Epithelial Cancer;   Malnutrition
Interventions: Device: Systematic ascites evacuation;   Procedure: Acute paracentesis.;   Behavioral: Interview.;   Behavioral: Quality of life.;   Behavioral: Nutritional status.
13 Not yet recruiting Follicular Steroid Genesis in Controlled Ovarian Stimulation
Conditions: Infertility;   Controlled Ovarian Hyperstimulation
Interventions: Drug: COS with GnRH antagonists and rFSH;   Drug: COS with GnRH antagonists and HP-HMG
14 Recruiting A Study of WT1 Vaccine and Nivolumab For Recurrent Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube;   Primary Peritoneal Cancer;   Recurrent Ovarian Cancer
Interventions: Biological: WT1 Vaccine;   Drug: Nivolumab
15 Recruiting Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: Regorafenib
16 Recruiting Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Applied to First Platinum-Resistant Recurrence of Ovarian Tumor
Condition: First Platinum-resistant Recurrent of Epithelial Ovarian Cancer
Intervention: Device: Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin
17 Not yet recruiting A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Conditions: Gynecologic Neoplasms;   Epithelial Ovarian Cancer;   Uterine Endometrial Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Intervention: Drug: Pembrolizumab
18 Not yet recruiting Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Conditions: Endometrial Endometrioid Adenocarcinoma;   Endometrial Mixed Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Endometrial Undifferentiated Carcinoma;   Metastatic Endometrioid Adenocarcinoma;   Recurrent Uterine Corpus Carcinoma
Interventions: Drug: Copanlisib;   Other: Laboratory Biomarker Analysis
19 Not yet recruiting Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer
Conditions: Malignant Neoplasms of Female Genital Organs;   Ovarian Cancer;   Primary Peritoneal Carcinoma;   Fallopian Tube Cancer
Interventions: Drug: Durvalumab;   Drug: Carboplatin;   Drug: Paclitaxel;   Behavioral: Questionnaires;   Procedure: Debulking Surgery
20 Not yet recruiting Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study
Condition: Ovarian Cancer
Intervention: Other: Immunohistochemistry staining method

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years